衰弱与肌少症替代指标与腹壁重建术后结局相关:全国数据库分析
该研究基于ACS-NSQIP数据库2015至2020年数据,回顾性纳入15466例择期腹壁重建成人患者,采用mFI-5评估衰弱、以BMI<20、体重丢失>10%、低白蛋白血症、血细胞比容<30%等替代指标定义肌少症,并经倾向性评分匹配分析。结果显示衰弱与肌少症替代指标均与术后总体并发症、主要并发症及非家庭出院风险升高独立相关,两者并存时风险最高,而30天死亡率与手术时间无显著差异。
要点
- 衰弱与肌少症替代指标在择期腹壁重建患者中较常见,分别为19.4%和11.3%。
- 衰弱与肌少症并存(双重损害)患者术后并发症风险最高。
- 将衰弱与肌少症纳入风险评估有助于患者选择、营养优化与预康复。
核心结论
- 衰弱与肌少症替代指标在择期腹壁重建患者中普遍存在,并独立关联术后并发症增加,两者并存时风险最大。
研究设计与样本
- 回顾性分析ACS-NSQIP数据库2015至2020年数据,纳入15466例择期腹壁重建成人患者,采用mFI-5评估衰弱,以≥1项验证替代指标定义肌少症,并行倾向性评分匹配及条件logistic回归。
主要发现
- 衰弱与总体并发症(OR 1.16,95%CI 1.01-1.32;p=0.035)、主要并发症(OR 1.27,95%CI 1.07-1.52;p=0.008)及非家庭出院(OR 1.40,95%CI 1.09-1.80;p=0.008)风险升高相关。
- 肌少症替代指标呈现类似关联。
- 衰弱与肌少症双重损害表型与并发症、主要并发症及非家庭出院风险最高相关。
- 匹配后30天死亡率与手术时间组间无显著差异。
临床怎么用
- 建议将衰弱与肌少症替代指标纳入腹壁重建术前风险评估,以辅助患者选择、营养优化与预康复策略制定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Abdominal wall reconstruction (AWR) carries significant postoperative morbidity, including surgical site infection, wound dehiscence, and readmission. Frailty and sarcopenia have emerged as critical predictors of surgical outcomes; however, their role in AWR is not well defined. We aimed to evaluate the independent and combined predictive value of frailty and sarcopenia proxies on morbidity and mortality after AWR. METHODS: A retrospective analysis using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database was conducted from 2015 to 2020. Frailty was assessed using the Modified Frailty Index (mFI-5), and sarcopenia proxies were defined by ≥ 1 validated proxy markers (BMI < 20, > 10% weight loss/malnutrition, hypoalbuminemia, hematocrit < 30%). Propensity score matching (PSM) was performed to create balanced cohorts, and conditional logistic regression on matched pairs was used to evaluate associations between frailty, sarcopenia proxies, and postoperative outcomes. Primary outcomes were 30-day morbidity and mortality. RESULTS: 15,466 adult patients undergoing elective AWR were included. Frailty and sarcopenia proxies were present in 19.4% and 11.3% of patients, respectively. After propensity score matching, frailty was associated with increased odds of overall morbidity (OR 1.16, 95% CI 1.01-1.32; p = 0.035), major complications (OR 1.27, 95% CI 1.07-1.52; p = 0.008), and discharge to a non-home facility (OR 1.40, 95% CI 1.09-1.80; p = 0.008). Sarcopenia proxies demonstrated similar associations. The combined frailty and sarcopenia-proxy phenotype (dual-impairment) conferred the highest odds of morbidity, major complications, and discharge to a non-home facility. Thirty-day mortality and operative time did not differ significantly between groups after matching. CONCLUSION: Frailty and sarcopenia proxies are prevalent among patients undergoing elective AWR and are independently associated with increased postoperative morbidity, with their coexistence (dual-impairment) conferring the greatest risk. Incorporating these factors into risk calculators may improve patient selection, nutritional optimization, and prehabilitation strategies in complex hernia repair.
引用
- Salas-Parra RD, Vintimilla B, Jou K, et al. Frailty and sarcopenia proxies are associated with postoperative outcomes after abdominal wall reconstruction: a national database analysis. Surg Endosc. 2026. PMID: 42576082. doi:10.1007/s00464-026-13216-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。